-
1
-
-
0028387858
-
'Substitution laws, insurance coverage, and generic drug use'
-
Anis, A. (1994). 'Substitution laws, insurance coverage, and generic drug use', Medical Care, 32 (3), 240-56.
-
(1994)
Medical Care
, vol.32
, Issue.3
, pp. 240-256
-
-
Anis, A.1
-
2
-
-
0035197496
-
'The impact of generic drug on brand name market shares: Evidence from micro data'
-
Aronson, T., M. Bergman and N. Rudholm (2001). 'The impact of generic drug on brand name market shares: Evidence from micro data', Review of Industrial Organization, 19, 425-35.
-
(2001)
Review of Industrial Organization
, vol.19
, pp. 425-435
-
-
Aronson, T.1
Bergman, M.2
Rudholm, N.3
-
3
-
-
0012950046
-
'A note on pricing monopoly and oligopoly'
-
Bain, J. (1949). 'A note on pricing monopoly and oligopoly', American Economic Review, 39, 448-64.
-
(1949)
American Economic Review
, vol.39
, pp. 448-464
-
-
Bain, J.1
-
6
-
-
0030886418
-
'A physician survey on generic drugs and substitution of critical dose medications'
-
Banahan, B. and E. Kolassa (1997). 'A physician survey on generic drugs and substitution of critical dose medications', Archives of Internal Medicine, 157, 2080-88.
-
(1997)
Archives of Internal Medicine
, vol.157
, pp. 2080-2088
-
-
Banahan, B.1
Kolassa, E.2
-
7
-
-
0029810531
-
'A prescribing incentive scheme for non-fundholding general practices: An observational study'
-
Bateman, D., M. Campbell, L. Donaldson, S. Roberts and J. Smith (1996). 'A prescribing incentive scheme for non-fundholding general practices: an observational study', British Medical Journal, 313, 535-38.
-
(1996)
British Medical Journal
, vol.313
, pp. 535-538
-
-
Bateman, D.1
Campbell, M.2
Donaldson, L.3
Roberts, S.4
Smith, J.5
-
8
-
-
45449114940
-
'The relative importance of actual and potential competition: Empirical evidence from the pharmaceutical market'
-
Bergman, M.A. and N. Rudholm (2003). 'The relative importance of actual and potential competition: Empirical evidence from the pharmaceutical market', The Journal of Industrial Economics, 60, 544-67.
-
(2003)
The Journal of Industrial Economics
, vol.60
, pp. 544-567
-
-
Bergman, M.A.1
Rudholm, N.2
-
9
-
-
0040077826
-
'Pharmaceuticals in US health care: Determinants of quantity and prices'
-
Berndt, E.R. (2002). 'Pharmaceuticals in US health care: Determinants of quantity and prices', Journal of Economic Perspectives, 16 (4), 45-66.
-
(2002)
Journal of Economic Perspectives
, vol.16
, Issue.4
, pp. 45-66
-
-
Berndt, E.R.1
-
11
-
-
0002304177
-
'Interesting times in German health policy'
-
Busse, R. (2001). 'Interesting times in German health policy', Eurohealth, 7 (2), 7-8.
-
(2001)
Eurohealth
, vol.7
, Issue.2
, pp. 7-8
-
-
Busse, R.1
-
12
-
-
85084275480
-
'Cost-containment in Germany 1977-97'
-
in E. Mossialos and J. LeGrand (eds.) Aldershot: Ashgate
-
Busse, R. and C. Howorth (1999). 'Cost-containment in Germany 1977-97', in E. Mossialos and J. LeGrand (eds.), Health Care and Cost Containment in the European Union, 303-39, Aldershot: Ashgate.
-
(1999)
Health Care and Cost Containment in the European Union
, pp. 303-339
-
-
Busse, R.1
Howorth, C.2
-
13
-
-
13444311084
-
'Pharmacists' individual and organizational views on generic medications'
-
Cage, A. (2001). 'Pharmacists' individual and organizational views on generic medications', Journal of the American Pharmaceutical Association, 41 (5), 723-28.
-
(2001)
Journal of the American Pharmaceutical Association
, vol.41
, Issue.5
, pp. 723-728
-
-
Cage, A.1
-
14
-
-
0002257846
-
'Patent expiration, entry, and competition in the US pharmaceutical industry: An exploratory analysis'
-
Washington: Brookings Institute
-
Caves, R.E., M.E. Whinston and M.A. Hurwitz (1991). 'Patent expiration, entry, and competition in the US pharmaceutical industry: An exploratory analysis', Brookings Papers on Economic Activity: Microeconomics, 1-66, Washington: Brookings Institute.
-
(1991)
Brookings Papers on Economic Activity: Microeconomics
, pp. 1-66
-
-
Caves, R.E.1
Whinston, M.E.2
Hurwitz, M.A.3
-
15
-
-
45449083580
-
-
CDER (Centre for Drug Evaluation and Research) Washington, DC: Centre for Drug Evaluation and Research, US Food and Drug Administration
-
CDER (Centre for Drug Evaluation and Research) (1998). 1998 Report to the Nation, Washington, DC: Centre for Drug Evaluation and Research, US Food and Drug Administration.
-
(1998)
1998 Report to the Nation
-
-
-
16
-
-
0034016802
-
'Effects of financial incentives on medical practice: Results from a systematic review of the literature and methodological issues'
-
April
-
Chaix-Couturier, C., I. Durand-Zaleski, D. Jolly and P. Durieux (2000). 'Effects of financial incentives on medical practice: Results from a systematic review of the literature and methodological issues', International Journal for Quality in Health Care, April, 12 (2), 133-42.
-
(2000)
International Journal for Quality in Health Care
, vol.12
, Issue.2
, pp. 133-142
-
-
Chaix-Couturier, C.1
Durand-Zaleski, I.2
Jolly, D.3
Durieux, P.4
-
17
-
-
34548860963
-
'Drug administration and good prescribing practice'
-
in E. Mossialos, M. Mrazek and T. Walley (eds.) (Chapter 8), Buckingham: Open University Press
-
Chapman, S., P. Durieux and T., Walley (2004). 'Drug administration and good prescribing practice', in E. Mossialos, M. Mrazek and T. Walley (eds.), Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality (Chapter 8), Buckingham: Open University Press.
-
(2004)
Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality
-
-
Chapman, S.1
Durieux, P.2
Walley, T.3
-
19
-
-
45449105137
-
'Changes to Ontario Formulary will mean big savings for health care system'
-
CDMA Winter
-
CDMA (1999). 'Changes to Ontario Formulary will mean big savings for health care system', Viewpoint-News from Canada's National Pharmaceutical Industry, Winter, 3-4.
-
(1999)
Viewpoint-News from Canada's National Pharmaceutical Industry
, pp. 3-4
-
-
-
20
-
-
0002809836
-
'The relative impact of actual and potential rivalry on firm profitability in the pharmaceutical industry'
-
Cool, K., L.H. Röller and B. Leleux (1999). 'The relative impact of actual and potential rivalry on firm profitability in the pharmaceutical industry', Strategic Management Journal, 20, 1-14.
-
(1999)
Strategic Management Journal
, vol.20
, pp. 1-14
-
-
Cool, K.1
Röller, L.H.2
Leleux, B.3
-
21
-
-
0031914249
-
'The economics of parallel trade'
-
Danzon, P.M. (1998), 'The economics of parallel trade', Pharmacoeconomics, 13 (3), 293-303.
-
(1998)
Pharmacoeconomics
, vol.13
, Issue.3
, pp. 293-303
-
-
Danzon, P.M.1
-
22
-
-
0034354072
-
'Does regulation drive out competition in pharmaceutical markets?'
-
Danzon, P.M. and L.W. Chao (2000). 'Does regulation drive out competition in pharmaceutical markets?', Journal of Law and Economics, 43 (2), 311-57.
-
(2000)
Journal of Law and Economics
, vol.43
, Issue.2
, pp. 311-357
-
-
Danzon, P.M.1
Chao, L.W.2
-
23
-
-
0034115999
-
'Importing budget systems from other countries: What can we learn from the German drug budget and the British GP fundholding?'
-
Delnoij, D. and G. Brenner (2000). 'Importing budget systems from other countries: What can we learn from the German drug budget and the British GP fundholding?', Health Policy, 52 (3), 157-69.
-
(2000)
Health Policy
, vol.52
, Issue.3
, pp. 157-169
-
-
Delnoij, D.1
Brenner, G.2
-
24
-
-
4243633005
-
'Generic drug prices and proposals to set maximum prices for generic medicines'
-
DH (UK Department of Health) Department of Health
-
DH (UK Department of Health) (2000). 'Generic drug prices and proposals to set maximum prices for generic medicines', Department of Health.
-
(2000)
-
-
-
26
-
-
45449088275
-
-
DH (UK Department of UK Department of Health, Gateway reference 6446, April, London (accessed 4 April 2008
-
DH (UK Department of Health) (2006). Practice Based Commissioning and Budget Setting, UK Department of Health, Gateway reference 6446, April, London (accessed 4 April 2008: http://www.dh.gov.uk/en/ Managingyourorganisation/Commissioning/Practice-basedcommissioning/ DH_4130824).
-
(2006)
Practice Based Commissioning and Budget Setting
-
-
-
27
-
-
0003664349
-
-
DHHS (US Department of Health & Human Services) Report to the President, DHSS, Washington, DC, April
-
DHHS (US Department of Health & Human Services) (2000). Prescription Drug Coverage, Spending, Utilization and Prices, Report to the President, DHSS, Washington, DC, April.
-
(2000)
Prescription Drug Coverage, Spending, Utilization and Prices
-
-
-
29
-
-
45449089229
-
-
EGA EGA Position Paper, European Generic Medicines Association, January
-
EGA (2004). Data Exclusivity vs Bolar Provision: A False 'Trade-off', EGA Position Paper, European Generic Medicines Association, January.
-
(2004)
Data Exclusivity Vs Bolar Provision: A False 'Trade-off'
-
-
-
30
-
-
0031221392
-
'Characteristics of demand for pharmaceutical products: An examination of four cephalosporins'
-
Ellison, S.F., I. Cockburn, Z. Griliches and J. Hausman (1997). 'Characteristics of demand for pharmaceutical products: An examination of four cephalosporins', RAND Journal of Economics, 28 (3), 426-46.
-
(1997)
RAND Journal of Economics
, vol.28
, Issue.3
, pp. 426-446
-
-
Ellison, S.F.1
Cockburn, I.2
Griliches, Z.3
Hausman, J.4
-
32
-
-
0002179168
-
'Distribution margins: A European overview'
-
Garattini, L. and F. Salvioni (1996). 'Distribution margins: A European overview', Pharma Pricing Review, 1 (8), 154-57.
-
(1996)
Pharma Pricing Review
, vol.1
, Issue.8
, pp. 154-157
-
-
Garattini, L.1
Salvioni, F.2
-
33
-
-
0034092020
-
'A comparative analysis of generic markets in five European countries'
-
Garattini, L. and F. Tediosi (2000). 'A comparative analysis of generic markets in five European countries', Health Policy, 51, 149-62.
-
(2000)
Health Policy
, vol.51
, pp. 149-162
-
-
Garattini, L.1
Tediosi, F.2
-
34
-
-
21344497267
-
'Measuring information in the market: An application to physicians services'
-
Gaynor, M. and S.W. Polachek (1994). 'Measuring information in the market: An application to physicians services', Southern Economic Journal, 60, 815-31.
-
(1994)
Southern Economic Journal
, vol.60
, pp. 815-831
-
-
Gaynor, M.1
Polachek, S.W.2
-
35
-
-
0031838934
-
'The German experience in reference pricing'
-
Giuliani, G., G. Selke and L. Garattini (1998). 'The German experience in reference pricing', Health Policy, 44, 73-85.
-
(1998)
Health Policy
, vol.44
, pp. 73-85
-
-
Giuliani, G.1
Selke, G.2
Garattini, L.3
-
36
-
-
0342577611
-
'Longer patents for lower imitation barriers: The 1984 Drug Act'
-
Grabowski, H. and J. Vernon (1986). 'Longer patents for lower imitation barriers: The 1984 Drug Act', American Economic Review, 76 (2), 195-98.
-
(1986)
American Economic Review
, vol.76
, Issue.2
, pp. 195-198
-
-
Grabowski, H.1
Vernon, J.2
-
37
-
-
84934453292
-
'Brand loyalty and price competition in pharmaceuticals after the 1984 Drug Act'
-
Grabowski, H. and J. Vernon (1992). 'Brand loyalty and price competition in pharmaceuticals after the 1984 Drug Act', Journal of Law and Economics, 35 (2), 331-50.
-
(1992)
Journal of Law and Economics
, vol.35
, Issue.2
, pp. 331-350
-
-
Grabowski, H.1
Vernon, J.2
-
38
-
-
0035900074
-
'Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs'
-
Grootendorst, P., L. Dolovich, B. O'Brien, A. Holbrook and A. Levy (2001). 'Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs', Canadian Medical Association Journal, 165 (8), 1011-19.
-
(2001)
Canadian Medical Association Journal
, vol.165
, Issue.8
, pp. 1011-1019
-
-
Grootendorst, P.1
Dolovich, L.2
O'Brien, B.3
Holbrook, A.4
Levy, A.5
-
39
-
-
0030446004
-
'Fundholders' prescribing costs: The first five years'
-
Harris, C.M. and G. Scrivener (1996). 'Fundholders' prescribing costs: the first five years', British Medical Journal, 313, 1531-34.
-
(1996)
British Medical Journal
, vol.313
, pp. 1531-1534
-
-
Harris, C.M.1
Scrivener, G.2
-
40
-
-
0030902465
-
'Changes in drug prescribing under the Public Health Reform Law - A survey of general practitioners' attitudes in East and West Germany'
-
Himmel, W., M. Kron, S. Thies-Zajonc and M. Kochen (1997). 'Changes in drug prescribing under the Public Health Reform Law -a survey of general practitioners' attitudes in East and West Germany', International Journal of Clinical Pharmacology and Therapeutics, 35 (4), 164-68.
-
(1997)
International Journal of Clinical Pharmacology and Therapeutics
, vol.35
, Issue.4
, pp. 164-168
-
-
Himmel, W.1
Kron, M.2
Thies-Zajonc, S.3
Kochen, M.4
-
41
-
-
0036906328
-
'The importance of being the first: Evidence from Canadian generic pharmaceuticals'
-
Hollis, A. (2002). 'The importance of being the first: Evidence from Canadian generic pharmaceuticals', Health Economics, 11 (8), 723-34.
-
(2002)
Health Economics
, vol.11
, Issue.8
, pp. 723-734
-
-
Hollis, A.1
-
42
-
-
0029882112
-
'A critical review of the remuneration system for pharmacists'
-
Huttin, C. (1996). 'A critical review of the remuneration system for pharmacists', Health Policy, 36, 53 D -68.
-
(1996)
Health Policy
, vol.36
, pp. 53-68
-
-
Huttin, C.1
-
43
-
-
0034971513
-
'Patents, brand generic competition and the pricing of ethical drugs in Canada: Some empirical evidence form British Columbia 1981-1994'
-
Jones, J.C.H., T. Potashnik and A. Zhang (2001). 'Patents, brand generic competition and the pricing of ethical drugs in Canada: Some empirical evidence form British Columbia 1981-1994', Applied Economics, 33, 947-56.
-
(2001)
Applied Economics
, vol.33
, pp. 947-956
-
-
Jones, J.C.H.1
Potashnik, T.2
Zhang, A.3
-
44
-
-
0028686330
-
'Pricing and reimbursement of pharmaceuticals in Sweden'
-
Jönsson, B. (1994). 'Pricing and reimbursement of pharmaceuticals in Sweden', Pharmacoeconomics, 6, Suppl 1, 51-60.
-
(1994)
Pharmacoeconomics
, vol.6
, Issue.SUPPL. 1
, pp. 51-60
-
-
Jönsson, B.1
-
47
-
-
33846666462
-
'Do generics offer significant savings to the UK National Health Service'
-
Kanavos, P. (2007). 'Do generics offer significant savings to the UK National Health Service', Current Medical Research and Opinion, 23 (1), 105-16.
-
(2007)
Current Medical Research and Opinion
, vol.23
, Issue.1
, pp. 105-116
-
-
Kanavos, P.1
-
48
-
-
34548309393
-
'Product differentiation, competition and regulation of new drugs: The case of statins in four European countries'
-
Kanavos, P., J. Costa Font and A.J. McGuire (2007). 'Product differentiation, competition and regulation of new drugs: The case of statins in four European countries', Managerial and Decision Economics, 28, 455-65.
-
(2007)
Managerial and Decision Economics
, vol.28
, pp. 455-465
-
-
Kanavos, P.1
Costa Font, J.2
McGuire, A.J.3
-
50
-
-
0032917876
-
'International comparisons of health care expenditures: What we know and what we do not know'
-
April
-
Kanavos, P. and E. Mossialos (1999). 'International comparisons of health care expenditures: What we know and what we do not know', Journal of Health Services Research and Policy, April, 4 (2), 122-26.
-
(1999)
Journal of Health Services Research and Policy
, vol.4
, Issue.2
, pp. 122-126
-
-
Kanavos, P.1
Mossialos, E.2
-
51
-
-
0037711369
-
'Reference pricing for drugs: Is it compatible with US health care?'
-
May-June
-
Kanavos, P. and U. Reinhardt (2003). 'Reference pricing for drugs: Is it compatible with US health care?', Health Affairs (Milwood), May-June, 22 (3), 16-30.
-
(2003)
Health Affairs (Milwood)
, vol.22
, pp. 16-30
-
-
Kanavos, P.1
Reinhardt, U.2
-
52
-
-
84889321553
-
'The impact of patent expiry on product competition and generic market entry: Evidence on ACE inhibitors from 4 European countries'
-
under review
-
Kanavos, P. and D. Srivastava (2007). 'The impact of patent expiry on product competition and generic market entry: Evidence on ACE inhibitors from 4 European countries', EUROPEAN Journal of Health Economics, under review.
-
(2007)
EUROPEAN Journal of Health Economics
-
-
Kanavos, P.1
Srivastava, D.2
-
53
-
-
0036689918
-
'Encouraging the use of generic medicines: Implications for transition economies'
-
King, D.R. and P. Kanavos (2002). 'Encouraging the use of generic medicines: Implications for transition economies', Croatian Medical Journal, 43 (4), 462-69.
-
(2002)
Croatian Medical Journal
, vol.43
, Issue.4
, pp. 462-469
-
-
King, D.R.1
Kanavos, P.2
-
54
-
-
33845331688
-
'Patients' attitudes towards and experiences of generic drug substitution in Norway'
-
October
-
Kjoenniksen, I., M. Lindbaek and A. Granas (2006). 'Patients' attitudes towards and experiences of generic drug substitution in Norway', Pharmacy World and Science, 28 (5), October, 284-89(6).
-
(2006)
Pharmacy World and Science
, vol.28
, Issue.5
, pp. 284-896
-
-
Kjoenniksen, I.1
Lindbaek, M.2
Granas, A.3
-
55
-
-
1642371481
-
'The effect of generic competition on the price of brand name drugs'
-
Lexchin, J. (2004). 'The effect of generic competition on the price of brand name drugs', Health Policy, 68 (1), 47-54.
-
(2004)
Health Policy
, vol.68
, Issue.1
, pp. 47-54
-
-
Lexchin, J.1
-
56
-
-
0034680689
-
'Review of the literature on reference pricing'
-
Lopez-Casasnovas, G. and J. Puig-Junoy (2000). 'Review of the literature on reference pricing', Health Policy, 54, 87-123.
-
(2000)
Health Policy
, vol.54
, pp. 87-123
-
-
Lopez-Casasnovas, G.1
Puig-Junoy, J.2
-
57
-
-
2742582756
-
'An evaluation of the PPRS: Is there a need for reform'
-
in D. Green (ed.) London: IEA
-
Mossialos, E. (1997). 'An evaluation of the PPRS: Is there a need for reform', in D. Green (ed.), Should Pharmaceutical Prices Be Regulated, London: IEA.
-
(1997)
Should Pharmaceutical Prices Be Regulated
-
-
Mossialos, E.1
-
59
-
-
28844504526
-
'The off-patent pharmaceutical market'
-
in E. Mossialos, M. Mrazek and T. Walley (eds.) Buckingham: Open University Press
-
Mrazek, M.F. and R. Frank (2004). 'The off-patent pharmaceutical market', in E. Mossialos, M. Mrazek and T. Walley (eds.), Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality, Buckingham: Open University Press.
-
(2004)
Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality
-
-
Mrazek, M.F.1
Frank, R.2
-
60
-
-
0034715984
-
'Increasing demand while decreasing costs of generic medicines'
-
Mrazek, M. and E.A. Mossialos (2000). 'Increasing demand while decreasing costs of generic medicines', The Lancet, 356 (9244), 1784-85.
-
(2000)
The Lancet
, vol.356
, Issue.9244
, pp. 1784-1785
-
-
Mrazek, M.1
Mossialos, E.A.2
-
61
-
-
45449106763
-
'GSG und die Auswirkungen in der Arztpraxis: Schwarzeck-Gerlag'
-
GmbH
-
Muller, H. (1994). 'GSG und die Auswirkungen in der Arztpraxis: Schwarzeck-Gerlag', GmbH.
-
(1994)
-
-
Muller, H.1
-
65
-
-
0031874329
-
'How competition lowers the costs of medicines'
-
Reekie, W.D. (1998). 'How competition lowers the costs of medicines', Pharmacoeconomics, 14 (Suppl.1), 107-13.
-
(1998)
Pharmacoeconomics
, vol.14
, Issue.SUPPL. 1
, pp. 107-113
-
-
Reekie, W.D.1
-
68
-
-
0034748817
-
'Pharmaceutical pricing and reimbursement in Spain'
-
Rovira, J. and J. Darbà(2001). 'Pharmaceutical pricing and reimbursement in Spain', HEPAC, 2, 39-43.
-
(2001)
HEPAC
, vol.2
, pp. 39-43
-
-
Rovira, J.1
Darbà, J.2
-
69
-
-
33747290660
-
'Consumer perceptions regarding generic drug substitution: An exploratory study'
-
Sansgiry, S., M. Bhosle and N. Pope (2006). 'Consumer perceptions regarding generic drug substitution: An exploratory study'. Journal of Pharmaceutical Marketing & Management, 17 (1), 77-93.
-
(2006)
Journal of Pharmaceutical Marketing & Management
, vol.17
, Issue.1
, pp. 77-93
-
-
Sansgiry, S.1
Bhosle, M.2
Pope, N.3
-
70
-
-
0029825923
-
'Consequences of implementing a drug budget for office-based physicians in Germany'
-
Schoffski, O. (1996). 'Consequences of implementing a drug budget for office-based physicians in Germany', Pharmacoeconomics, 10 (2), 37-47.
-
(1996)
Pharmacoeconomics
, vol.10
, Issue.2
, pp. 37-47
-
-
Schoffski, O.1
-
71
-
-
0033195434
-
'Entry decision in the generic pharmaceutical industry'
-
Scott-Morton, F.M. (1999). 'Entry decision in the generic pharmaceutical industry', Rand Journal of Economics, 30, 421-40.
-
(1999)
Rand Journal of Economics
, vol.30
, pp. 421-440
-
-
Scott-Morton, F.M.1
-
73
-
-
0030758635
-
'Hospital pharmacy decisions, cost containment and the use of cost-effectiveness analysis'
-
Sloan, F., K. Whetten-Goldstein and A. Wilson (1997). 'Hospital pharmacy decisions, cost containment and the use of cost-effectiveness analysis', Social Science and Medicine, 45 (4), 523-33.
-
(1997)
Social Science and Medicine
, vol.45
, Issue.4
, pp. 523-533
-
-
Sloan, F.1
Whetten-Goldstein, K.2
Wilson, A.3
-
74
-
-
0004274851
-
-
(trans. Alan T. Peacock), New York: Oxford University Press
-
Stackelberg, H. (1952). The Theory of the Market Economy (trans. Alan T. Peacock), 194-204, New York: Oxford University Press.
-
(1952)
The Theory of the Market Economy
, pp. 194-204
-
-
Stackelberg, H.1
-
75
-
-
84889337177
-
'Managed care and generic pharmaceuticals'
-
in Barcelona, Spain, June
-
Strollo, M. (1999). 'Managed care and generic pharmaceuticals', in IGPA Conference, Barcelona, Spain, June.
-
(1999)
IGPA Conference
-
-
Strollo, M.1
-
76
-
-
0031729446
-
'Price trends before and after patent expiration in the pharmaceutical industry'
-
Suh, D.C., S. Schondelmeyer, W. Manning, R. Hadsall and J. Nyman (1999). 'Price trends before and after patent expiration in the pharmaceutical industry', Journal of Research in Pharmaceutical Economics, 9 (2), 17-32.
-
(1999)
Journal of Research in Pharmaceutical Economics
, vol.9
, Issue.2
, pp. 17-32
-
-
Suh, D.C.1
Schondelmeyer, S.2
Manning, W.3
Hadsall, R.4
Nyman, J.5
-
78
-
-
56649098238
-
'Financial incentives and prescribing'
-
in E. Mossialos, M. Mrazek, and T. Walley (eds.) Chapter 10, Buckingham: Open University Press
-
Walley, T. and E. Mossialos (2004). 'Financial incentives and prescribing', in E. Mossialos, M. Mrazek, and T. Walley (eds.), Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality, Chapter 10, Buckingham: Open University Press.
-
(2004)
Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality
-
-
Walley, T.1
Mossialos, E.2
-
80
-
-
0030887271
-
'GP fundholding and the costs of prescribing: Further results'
-
Whynes, D., D. Baines and K. Tolley (1997). 'GP fundholding and the costs of prescribing: Further results', Journal of Public Health Medicine, 19 (1), 18-22.
-
(1997)
Journal of Public Health Medicine
, vol.19
, Issue.1
, pp. 18-22
-
-
Whynes, D.1
Baines, D.2
Tolley, K.3
-
81
-
-
2442529778
-
'Price competition in pharmaceuticals: The case of anti-infectives'
-
Wiggins, S.N. and R.S. Maness (2004). 'Price competition in pharmaceuticals: The case of anti-infectives', Economic Inquiry, 42, 247-62.
-
(2004)
Economic Inquiry
, vol.42
, pp. 247-262
-
-
Wiggins, S.N.1
Maness, R.S.2
-
82
-
-
0028807483
-
'Alterations in prescribing by general practitioner fundholders: An observational study'
-
Wilson, R., I. Buchan and T. Walley (1995). 'Alterations in prescribing by general practitioner fundholders: An observational study', British Medical Journal, 311, 1347-50.
-
(1995)
British Medical Journal
, vol.311
, pp. 1347-1350
-
-
Wilson, R.1
Buchan, I.2
Walley, T.3
-
83
-
-
0028272964
-
'Prescribing generic drugs'
-
Young, J. (1994). 'Prescribing generic drugs', British Journal of General Practice, 44 (380), 139-40.
-
(1994)
British Journal of General Practice
, vol.44
, Issue.380
, pp. 139-140
-
-
Young, J.1
|